Matthew Calistri | Vice President of Investor Relations |
Tony Coles | Chairperson & Chief Executive Officer |
Ray Sanchez | Chief Medical Officer |
John Renger | Chief Scientific Officer |
Kathy Yi | Chief Financial Officer |
Paul Matteis | Stifel |
Michael Yee | Jefferies |
Kostas Biliouris | Morgan Stanley |
Greg Suvannavejh | Goldman Sachs |
Good morning. Welcome to the Cerevel Therapeutics Second Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the Q&A portion of the call. Please note that this call maybe recorded.